The Searle Company Limited (PSX: SEARL)

Market Cap	29.54B
Revenue (ttm)	36.33B
Net Income (ttm)	-1.09B
Shares Out	511.49M
EPS (ttm)	-2.25
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	780,914
Open	57.80
Previous Close	57.44
Day's Range	57.25 - 58.45
52-Week Range	34.60 - 64.09
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 30, 2024

About The Searle Company

The Searle Company Limited manufactures and sells pharmaceutical and other consumer products in Pakistan. The company offers pharmaceutical products in the therapeutic areas of cardiovascular, respiratory care, gastroenterology, pain management, CNS, orthocare, neuropsychiatry, probiotics, antibiotics, and nutritional care. It also provides nutraceutical products, as well as medical devices and disposables. The Searle Company Limited was incorporated in 1965 and is based in Karachi, Pakistan. The Searle Company Limited is a subsidiary of Intern...

• Industry: Pharmaceuticals
• Sector: Healthcare
• Founded: 1965
• Employees: 2,716
• Stock Exchange: Pakistan Stock Exchange
• Ticker Symbol: SEARL

Financial Performance

In 2023, The Searle Company's revenue was 33.90 billion, an increase of 13.34% compared to the previous year's 29.91 billion. Earnings were 313.71 million, a decrease of -86.66%.